Carboxytherapy in the Treatment of Atrophic Scars

Atrophic Scar Clinical Trial

Official title:

Efficacy of Carboxy Therapy Versus Fractional Laser CO2 Versus Platelet Rich Plasma in Atrophic Scars, a Comparative Study.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05695807
• Other study ID #: Carboxytherapy atrophic scar
• Status: Not yet recruiting
• Phase: N/A
• Start date: February 1, 2023
• Est. completion date: July 1, 2023

Study information

• Verified date: January 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To evaluate the efficacy of CO2 versus fractional CO2 laser versus platelet rich plasma in treatment of atrophic scars using clinical assessment and ultrasonography

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: July 1, 2023
• Est. primary completion date: June 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• traumatic and surgical scar

Exclusion Criteria:

• active infections

Related Conditions & MeSH terms

• Atrophic Scar
• Atrophy

Intervention

Device:
• Carboxytherapy
Device generating CO2 gas

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Modified Vancouver score		12 weeks